Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8856029rdf:typepubmed:Citationlld:pubmed
pubmed-article:8856029lifeskim:mentionsumls-concept:C0021338lld:lifeskim
pubmed-article:8856029lifeskim:mentionsumls-concept:C1136102lld:lifeskim
pubmed-article:8856029lifeskim:mentionsumls-concept:C0242831lld:lifeskim
pubmed-article:8856029pubmed:issue8lld:pubmed
pubmed-article:8856029pubmed:dateCreated1996-11-19lld:pubmed
pubmed-article:8856029pubmed:abstractTextTwenty hybridoma cell lines producing monoclonal antibodies (MAbs) against serotype 1 infectious bursal disease virus (IBDV) of GBF-1 and the attenuated GBF-1E strains were produced. The MAbs recognized major structural proteins VP2 and VP3. MAb recognition sites were mapped using recombinant Escherichia coli clones which expressed N-terminal and (or) C-terminal truncated virus antigens, and competitive-binding assays. At least 3 conformation-dependent serotype 1 specific virus neutralizing antigenic sites and a linear antigenic site were defined on VP2 and VP3, respectively. Two of the conformational virus neutralizing antigenic sites were localized in the central area of VP2 consisting of 156 amino acid residues, and the linear epitope was localized in C-terminal 105 amino acid residues of VP3. Another conformational virus neutralizing antigenic site recognized with the virus neutralizing MAb GK-5 was not defined because GK-5 did not react with virus antigen expressed in recombinant E. coli. The conformational antigenic site was supposed to be composed of tertiary or quaternary protein structure, which may not be constructed in recombinant E. coli.lld:pubmed
pubmed-article:8856029pubmed:languageenglld:pubmed
pubmed-article:8856029pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8856029pubmed:citationSubsetIMlld:pubmed
pubmed-article:8856029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8856029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8856029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8856029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8856029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8856029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8856029pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8856029pubmed:statusMEDLINElld:pubmed
pubmed-article:8856029pubmed:issn0304-8608lld:pubmed
pubmed-article:8856029pubmed:authorpubmed-author:YamaguchiTTlld:pubmed
pubmed-article:8856029pubmed:authorpubmed-author:KobayashiMMlld:pubmed
pubmed-article:8856029pubmed:authorpubmed-author:HiraiKKlld:pubmed
pubmed-article:8856029pubmed:authorpubmed-author:OgawaMMlld:pubmed
pubmed-article:8856029pubmed:authorpubmed-author:IwataKKlld:pubmed
pubmed-article:8856029pubmed:authorpubmed-author:FukushiHHlld:pubmed
pubmed-article:8856029pubmed:issnTypePrintlld:pubmed
pubmed-article:8856029pubmed:volume141lld:pubmed
pubmed-article:8856029pubmed:ownerNLMlld:pubmed
pubmed-article:8856029pubmed:authorsCompleteYlld:pubmed
pubmed-article:8856029pubmed:pagination1493-507lld:pubmed
pubmed-article:8856029pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:meshHeadingpubmed-meshheading:8856029-...lld:pubmed
pubmed-article:8856029pubmed:year1996lld:pubmed
pubmed-article:8856029pubmed:articleTitleEpitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.lld:pubmed
pubmed-article:8856029pubmed:affiliationDepartment of Veterinary Microbiology, Faculty of Agriculture, Gifu University, Japan.lld:pubmed
pubmed-article:8856029pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8856029pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8856029lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8856029lld:pubmed